| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.067 | 0.04 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.04 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.069 | 0.04 |
| mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.04 |